Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-02

Clinical Trial Update: Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention) [Phase 2]

View source ↗

Summary

Clinical trial update noting completion of a Phase 2 study evaluating the dietary supplement Anatabloc for autoimmune thyroiditis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anatabloc

Snippet

Sponsor: Rock Creek Pharmaceuticals, Inc. | Conditions: Thyroiditis, Autoimmune | Phase 2 | Status: COMPLETED